Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

SHA:600613 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	29.33	38.24	71.39	57	48.55	69.62
Depreciation & Amortization	90.02	86.71	91.5	93.29	96.43	66.11
Other Amortization	1.67	1.71	1.13	0.75	0.81	2.11
Loss (Gain) From Sale of Assets	-0.28	-0.23	0.12	-0.27	5.17	0
Asset Writedown & Restructuring Costs	8.34	0.01	1.72	55.78	2.78	27.89
Loss (Gain) From Sale of Investments	-4.06	-3.54	-1.23	-1.71	-1.77	-28.11
Provision & Write-off of Bad Debts	19.82	19.82	16.2	-34.98	5.34	-15.83
Other Operating Activities	25.99	28.39	28.39	20	27.03	-1.8
Change in Accounts Receivable	41.66	8.94	100.43	100.94	-25.11	-231.77
Change in Inventory	-33.03	14.5	9.47	-22.85	-26.64	-3.25
Change in Accounts Payable	-1.08	-68.88	-110.68	-59.47	186.91	294.47
Operating Cash Flow	175.42	124.47	207.79	215.59	319.23	184.26
Operating Cash Flow Growth	32.55%	-40.09%	-3.62%	-32.47%	73.25%	85.94%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-21.35	-33.22	-36.39	-24.51	-26.64	-85.96
Sale of Property, Plant & Equipment	0.12	0.06	0.39	4.3	0.17	0.12
Divestitures	-	-	-	-	-	1.67
Investment in Securities	-191.58	-170	0.03	-20	0.3	-3.11
Other Investing Activities	2.93	2.87	1.05	0.46	1.7	1.69
Investing Cash Flow	-209.88	-200.29	-34.92	-39.75	-24.47	-85.58

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	61.88	32	28.86	23.78	8.15
Total Debt Issued	69.88	61.88	32	28.86	23.78	8.15
Long-Term Debt Repaid	-	-82.79	-74.9	-87.88	-86.76	-90.47
Lease Payments	-12.27	-12.27	-15.32	-13.04	-13.6	-16.49
Total Debt Repaid	-194.1	-82.79	-74.9	-87.88	-86.76	-90.47
Net Debt Issued (Repaid)	-124.22	-20.92	-42.9	-59.02	-62.98	-82.33
Common Dividends Paid	-42.63	-88.22	-64.18	-66.29	-68.97	-3.97
Other Financing Activities	0.52	-0.32	-0.5	9.19	-1.99	-
Financing Cash Flow	-166.33	-109.46	-107.58	-116.12	-133.93	-86.3

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.25	-0.03	-0.18	0	0	-0
Net Cash Flow	-201.04	-185.3	65.1	59.72	160.82	12.39

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	154.08	91.26	171.39	191.08	292.59	98.3
Free Cash Flow Growth	83.27%	-46.76%	-10.30%	-34.70%	197.65%	3421.80%
Free Cash Flow Margin	8.38%	4.67%	8.37%	8.16%	12.25%	4.27%
Free Cash Flow Per Share	0.28	0.17	0.31	0.37	0.54	0.18
Levered Free Cash Flow	182.12	77.86	180.74	127.79	235.59	2.14
Unlevered Free Cash Flow	188.42	84.15	188.74	137.02	246.44	7.35
Free Cash Flow After Leases	141.8	78.98	156.07	178.04	278.99	81.81

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	180.68	181.61	166.89	229.78	196.1	205.93
Change in Working Capital	4.59	-46.64	-1.42	25.72	134.88	64.28

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error